Evidence map›Paper›PMID 35488281›Full record

ArticleBMC medical genomics2022

Pathogenic variants carrier screening in New Brunswick: Acadians reveal high carrier frequency for multiple genetic disorders.

Philippe Pierre Robichaud, Eric P Allain, Sarah Belbraouet, Claude Bhérer, Jean Mamelona, Jason Harquail, Stéphanie Crapoulet, Nicolas Crapoulet, Mathieu Bélanger, Mouna Ben Amor

Open access · goldAbstract read
In one paragraph

Article in BMC medical genomics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Expanding the Genetic Landscape ofNeurology. Genetics · 2026
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Philippe Pierre Robichaud *Department of Medical Genetics, Vitalité Health Network, Dr. Georges-L.-Dumont University Hospital Centre, 330 University Ave., Moncton, NB, E1C 2Z3, Canada.
Eric P Allain *Department of Medical Genetics, Vitalité Health Network, Dr. Georges-L.-Dumont University Hospital Centre, 330 University Ave., Moncton, NB, E1C 2Z3, Canada.
Sarah BelbraouetCentre de formation médicale du Nouveau-Brunswick, Moncton, NB, Canada.
Claude BhérerDepartment of Human Genetics, Faculty of Medicine and Health Sciences, McGill University, Montréal, QC, Canada.
Jean MamelonaResearch and Scientific Development, Vitalité Health Network, Moncton, NB, Canada.
Jason HarquailResearch and Scientific Development, Vitalité Health Network, Moncton, NB, Canada.
Stéphanie CrapouletResearch and Scientific Development, Vitalité Health Network, Moncton, NB, Canada.
Nicolas CrapouletDepartment of Medical Genetics, Vitalité Health Network, Dr. Georges-L.-Dumont University Hospital Centre, 330 University Ave., Moncton, NB, E1C 2Z3, Canada.
Mathieu BélangerCentre de formation médicale du Nouveau-Brunswick, Moncton, NB, Canada.
Mouna Ben AmorDepartment of Medical Genetics, Vitalité Health Network, Dr. Georges-L.-Dumont University Hospital Centre, 330 University Ave., Moncton, NB, E1C 2Z3, Canada. mouna.benamor@vitalitenb.ca.
Vitalité Health Network · CAAtlantic Cancer Research Institute · CADr. Georges-L.-Dumont University Hospital Centre · CAMcGill University · CAUniversité de Moncton · CAUniversité de Sherbrooke · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFounder populations that have recently undergone important genetic bottlenecks such as French-Canadians and Ashkenazi Jews can harbor some pathogenic variants at a higher carrier rate than the general population, putting them at a higher risk for certain genetic diseases. In these populations, there can be considerable benefit to performing ethnic-based or expanded preconception carrier screening, which can help in the prevention or early diagnosis and management of some genetic diseases. Acadians are descendants of French immigrants who settled in the Atlantic Coast of Canada in the seventeenth century. Yet, the Acadian population has never been investigated for the prevalence/frequency of disease-causing genetic variants.

methodsAn exome sequencing panel for 312 autosomal recessive and 30 X-linked diseases was designed and specimens from 60 healthy participants were sequenced to assess carrier frequency for the targeted diseases.

resultsIn this study, we show that a sample population of Acadians in South-East New Brunswick harbor variants for 28 autosomal recessive and 1 X-linked diseases, some of which are significantly more frequent in comparison to reference populations.

conclusionResults from this pilot study suggests a need for further investigation of genomic variation in this population and possibly implementation of targeted carrier and neonatal screening programs.

Indexed as

EthnicityCanadaExome SequencingHumansInfant, NewbornNew BrunswickPilot ProjectsAcadiansCarrier screeningFounder populationInherited disease

Identifiers

PMID35488281
PMCPMC9055701
OpenAlexW4225114510

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.